Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Market Analysis & Valuation

UpdatedJan 29, 2026
DataAggregated Company Financials
Companies133
  • 7D1.3%
  • 3M12.5%
  • 1Y-16.3%
  • YTD6.8%

In the last week, the market is up 1.3% led by Healthcare sector. In contrast, the Materials sector is lagging, dropping 4.0%. Over the past year the market is down 16%. As for the next few years, earnings are expected to grow by 5.6% per annum.

Trending IndustriesBiotech

Market Valuation and Performance

Has the Danish Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 29 Jan 2026DKK 4.5tDKK 1.9tDKK 260.3b16.8x17.2x2.3x
Sat, 27 Dec 2025DKK 4.2tDKK 1.9tDKK 260.5b16.2x16x2.1x
Mon, 24 Nov 2025DKK 3.9tDKK 2.0tDKK 262.5b14.8x14.9x2x
Wed, 22 Oct 2025DKK 4.2tDKK 1.9tDKK 287.8b15.1x14.4x2.1x
Fri, 19 Sep 2025DKK 4.1tDKK 1.9tDKK 287.0b15.3x14.5x2.2x
Sun, 17 Aug 2025DKK 3.9tDKK 1.9tDKK 280.3b14.8x13.8x2x
Tue, 15 Jul 2025DKK 4.4tDKK 1.9tDKK 262.0b15.8x16.8x2.4x
Thu, 12 Jun 2025DKK 4.8tDKK 1.9tDKK 263.0b15.8x18.4x2.6x
Sat, 10 May 2025DKK 4.4tDKK 1.9tDKK 266.9b15.1x16.3x2.3x
Mon, 07 Apr 2025DKK 4.1tDKK 1.9tDKK 260.3b13x15.8x2.2x
Wed, 05 Mar 2025DKK 5.3tDKK 1.9tDKK 263.2b13.8x20x2.8x
Fri, 31 Jan 2025DKK 5.2tDKK 1.8tDKK 238.1b14.1x21.7x2.8x
Sun, 29 Dec 2024DKK 5.3tDKK 1.8tDKK 238.2b13.9x22.4x2.9x
Tue, 26 Nov 2024DKK 5.8tDKK 1.8tDKK 237.6b14.6x24.5x3.2x
Thu, 24 Oct 2024DKK 6.1tDKK 1.7tDKK 180.2b15.2x33.7x3.5x
Sat, 21 Sep 2024DKK 6.4tDKK 1.7tDKK 180.0b16.1x35.5x3.7x
Mon, 19 Aug 2024DKK 6.6tDKK 1.7tDKK 180.2b16.8x36.8x3.8x
Wed, 17 Jul 2024DKK 6.8tDKK 1.7tDKK 185.3b15.6x36.9x4x
Fri, 14 Jun 2024DKK 7.0tDKK 1.7tDKK 184.7b15.5x37.7x4.1x
Sun, 12 May 2024DKK 6.5tDKK 1.7tDKK 183.8b14.7x35.1x3.8x
Tue, 09 Apr 2024DKK 6.4tDKK 1.7tDKK 192.3b15x33.2x3.7x
Thu, 07 Mar 2024DKK 6.3tDKK 1.7tDKK 191.8b13.2x32.7x3.7x
Sat, 03 Feb 2024DKK 6.0tDKK 1.8tDKK 225.0b14.1x26.5x3.3x
Mon, 01 Jan 2024DKK 5.5tDKK 1.8tDKK 216.0b14.2x25.7x3.1x
Wed, 29 Nov 2023DKK 5.3tDKK 1.8tDKK 216.1b13.2x24.7x3x
Fri, 27 Oct 2023DKK 5.2tDKK 1.9tDKK 284.4b12.4x18.3x2.8x
Sun, 24 Sep 2023DKK 5.3tDKK 1.9tDKK 283.7b13.1x18.6x2.8x
Tue, 22 Aug 2023DKK 5.3tDKK 1.9tDKK 281.2b13.3x18.7x2.8x
Thu, 20 Jul 2023DKK 5.0tDKK 1.9tDKK 318.4b13.4x15.8x2.6x
Sat, 17 Jun 2023DKK 5.2tDKK 1.9tDKK 322.1b13.8x16x2.7x
Mon, 15 May 2023DKK 5.3tDKK 1.9tDKK 322.8b14.2x16.5x2.8x
Wed, 12 Apr 2023DKK 4.9tDKK 1.9tDKK 343.9b15x14.2x2.6x
Fri, 10 Mar 2023DKK 4.8tDKK 1.9tDKK 348.8b14.2x13.8x2.5x
Sun, 05 Feb 2023DKK 4.7tDKK 1.9tDKK 356.0b14.1x13.2x2.5x
Price to Earnings Ratio

13.2x


Total Market Cap: DKK 4.7tTotal Earnings: DKK 356.0bTotal Revenue: DKK 1.9tTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Market Price to Earnings3Y Average 22.2x202420252026
Current Market PE
  • Investors are pessimistic on the Danish market, indicating that they anticipate earnings will not grow as fast as they have historically.
  • The market is trading at a PE ratio of 17.2x which is lower than its 3-year average PE of 22.2x.
Past Earnings Growth
  • The earnings for Danish listed companies have declined 9.9% per year over the last three years.
  • Meanwhile revenues have been flat.
  • This means that either the cost of doing business or the level of investment back into businesses is increasing since sales have remained steady while profits have fallen.

Sector Trends

Which sectors have driven the changes within the Danish Market?

DK Market1.31%
Utilities13.11%
Telecom4.08%
Energy4.01%
Tech2.43%
Industrials1.98%
Healthcare1.09%
Real Estate0.81%
Financials0.087%
Consumer Staples-0.23%
Materials-3.97%
Consumer Discretionary-4.07%
Sector PE
  • Investors favour the Tech sector the most for future growth, which is trading close to its 3-year average PE ratio of 52.4x.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 55.6% which is higher than its past year's earnings decline of 17.5% per year.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 56% over the next 5 years.
  • This is better than its past earnings decline of 17% per year.
  • In contrast, the Energy sector is expected to see its earnings decline by 35% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
MAERSK B A.P. Møller - MærskDKK 15.55k4.6%
+DKK 9.7b		47.9%PE7.4xIndustrials
ORSTED ØrstedDKK 142.104.8%
+DKK 8.7b		-48.8%PS2.6xUtilities
VWS Vestas Wind SystemsDKK 187.904.4%
+DKK 7.8b		85.4%PE26.6xIndustrials
NKT NKTDKK 814.004.8%
+DKK 2.0b		68.5%PE26.1xIndustrials
TRMD A TORMDKK 150.806.2%
+DKK 886.7m		6.5%PE8.9xEnergy
See more

Market Insights

Header cover image
How to invest when commodity prices get messy ⚖️
Richard Bowman avatar
Richard Bowman
|
|
From miners to energy, 2026 may reward structure and margins over spot price bets.
Continue reading
Why Didn’t Oil React to Venezuela? 🇻🇪
Last Week

Why Didn’t Oil React to Venezuela? 🇻🇪

Latest News

TRYG
DKK 151.10
Tryg
7D
-6.0%
1Y
3.3%
DSV
DKK 1,735.00
DSV
7D
-0.5%
1Y
18.8%

DSV: Freight Cycle Recovery Hopes And Margin Discipline Will Shape Future Returns

Analysts have raised their fair value estimate for DSV from DKK 1,825.84 to DKK 1,901.25. This revision reflects higher Street price targets and updated assumptions for the discount rate, revenue growth, profit margins, and future P/E multiples.
FLS
DKK 551.00
FLSmidth
7D
3.4%
1Y
47.6%

FLS: Capital Markets Day And Index Inclusion Will Shape Balanced Outlook

Analysts have lifted their fair value estimate for FLSmidth from DKK 470.78 to about DKK 500.20, citing recent price target moves around DKK 505 to DKK 540 and upcoming company events as key support for the revised view. Analyst Commentary Bullish Takeaways Bullish analysts point to the higher price target of DKK 540 as support for a valuation view that still sees upside potential versus the current fair value estimate of about DKK 500.20.
COLO B
DKK 541.40
Coloplast
7D
-2.1%
1Y
-35.2%

Coloplast A/S' (CPH:COLO B) P/E Is On The Mark

Jan 25
Coloplast A/S' (CPH:COLO B) P/E Is On The Mark
MAERSK B
DKK 15,275.00
A.P. Møller - Mærsk
7D
2.9%
1Y
48.2%

MAERSK B: Prolonged Transport Weakness Will Outweigh Profit Margins Going Forward

Analysts have trimmed their fair value estimate for A.P. Møller - Mærsk from DKK 11,991.74 to DKK 11,589.21, reflecting more cautious price targets after several recent downgrades and mixed target revisions across major banks. Analyst Commentary Recent research on A.P. Møller - Mærsk points to a split view, with some analysts trimming targets and ratings while others still see room for value at different price levels.
NOVO B
DKK 381.45
Novo Nordisk
7D
2.0%
1Y
-37.2%

NOVO B: Wegovy Pill Launch And Execution Discipline Will Support Future Upside

Analysts have reduced their fair value estimate for Novo Nordisk to €540 from €612. They cite more moderate assumptions for revenue growth and profit margins, along with a higher discount rate and a slightly higher expected future P/E multiple.
NKT
DKK 822.50
NKT
7D
4.4%
1Y
70.6%

NKT: Order Backlog Execution Will Support Sector-Leading Margins By 2028

Analysts have trimmed their fair value estimate for NKT to DKK 1,008 from DKK 1,097, reflecting updated views on growth, profitability and valuation multiples following recent downgrades and mixed price target revisions across the Street. Analyst Commentary Street research on NKT has been mixed recently, with some firms turning more cautious on the shares while others see enough execution progress and market opportunity to justify higher valuation benchmarks.
DANSKE
DKK 320.30
Danske Bank
7D
2.0%
1Y
46.3%

DANSKE: Future Repricing Risk Seen As Earnings Outpace Lower P E Assumptions

Analysts have lifted their price targets on Danske Bank, with recent moves such as DKK 352 to DKK 358, DKK 308 to DKK 319 and DKK 275 to DKK 295. These changes reflect updated views on revenue growth, profit margins and a lower assumed future P/E multiple in the refreshed valuation work.
VWS
DKK 190.70
Vestas Wind Systems
7D
7.1%
1Y
94.7%

VWS: Higher Price View Will Face Pressure From Execution And Margin Risks

Analysts have lifted their price target on Vestas Wind Systems, with one recent move taking it to DKK 173 from DKK 164. The change reflects updates to fair value assumptions, discount rate, revenue growth expectations, profit margin outlook and future P/E inputs.
ROCK B
DKK 215.10
Rockwool
7D
4.5%
1Y
-15.4%

ROCK B: Bullish Coverage And Buybacks Are Expected To Support Rebound

Analysts have trimmed their fair value estimate for Rockwool from DKK 359.88 to DKK 280.16, reflecting updated assumptions for slower revenue growth, slightly lower margins and a more cautious future P/E, even as recent research includes both new bullish coverage and moderated price targets. Analyst Commentary Recent research on Rockwool shows a mix of caution and optimism, with several bullish analysts focusing on valuation support, an improving earnings backdrop and potential for more balanced execution after previous downgrades.
PNDORA
DKK 487.00
Pandora
7D
-5.9%
1Y
-64.6%

PNDORA: Lower Margin Outlook Will Shape Measured Expectations For Future Earnings Multiple

Analysts now see Pandora's fair value at €510, down from €630. They cite modestly lower revenue growth and profit margin assumptions, along with a slightly higher discount rate and a trimmed future P/E estimate.
GMAB
DKK 2,049.00
Genmab
7D
-1.9%
1Y
47.0%

GMAB: Phase 3 Setback And 2026 Readout Will Shape Market Outlook

Genmab’s analyst price target has been lifted by roughly DKK 100 to reflect updated expectations around slightly higher revenue growth and profit margin assumptions, as analysts point to recent target increases from DKK 2,000 to DKK 2,400 and DKK 2,500 as support for a higher fair value range. Analyst Commentary Recent Street research on Genmab reflects a generally constructive stance, with higher price targets and continued attention on upcoming clinical milestones.
KBHL
DKK 6,260.00
Københavns Lufthavne
7D
-3.7%
1Y
-1.9%
ORSTED
DKK 146.20
Ørsted
7D
13.1%
1Y
-46.0%
CHEMM
DKK 608.50
ChemoMetec
7D
-13.5%
1Y
9.1%
NSIS B
DKK 390.70
Novozymes
7D
-4.2%
1Y
-4.5%